Header image

WITH THANKS TO OUR PLATINUM SPONSOR:
 

BioNTech is a global biotechnology company pioneering novel investigational therapies for cancer and other serious diseases. Leveraging deep expertise in mRNA technology, BioNTech develops and manufactures innovative mRNA-based vaccines and immunotherapies, advancing the frontiers of personalised medicine. In Australia, BioNTech has established a strategic partnership with mRNA Victoria to strengthen the local mRNA ecosystem and accelerate translational research by building an Innovation Centre and mRNA manufacturing capabilities.
The BioNTech Innovation Centre in Melbourne provides tailored mentoring and advisory services, supporting researchers and biotech startups in advancing their discoveries from laboratory to clinic. The Innovation Centre is complemented by a state-of-the-art research laboratory and clinical manufacturing facility at La Trobe University, designed to produce investigational mRNA medicines for clinical trials and support local R&D efforts. In addition, BioNTech intends to progress the development of investigational cancer treatments with a goal to treat up to 4,000 cancer patients in Australia and New Zealand over the next decade, either in clinical trials or as authorized treatments. 

 

loading